Adrenocorticotropic Hormone [EPC]

Adrenocorticotropic Hormone [EPC] was reported 895 times

Drugs of the Adrenocorticotropic Hormone [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 NONINFECTIVE CHORIORETINITIS 3 0.1000
1 SARCOIDOSIS OF LYMPH NODE 5 0.0820
2 ABSENCE OF IMMEDIATE TREATMENT RESPONSE 15 0.0633
3 OCULAR PEMPHIGOID 7 0.0560
4 KERATITIS INTERSTITIAL 2 0.0392
5 INJECTION SITE DISCHARGE 117 0.0217
6 JOINT SPACE NARROWING 4 0.0134
7 PULMONARY SARCOIDOSIS 14 0.0125
8 NAIL PIGMENTATION 3 0.0124
9 CORNEAL SCAR 6 0.0119
10 CORNEAL TRANSPLANT 9 0.0115
11 CUTANEOUS CALCIFICATION 2 0.0109
12 NEUROSARCOIDOSIS 4 0.0106
13 POLYMYOSITIS 18 0.0102
14 CORTISOL ABNORMAL 2 0.0101
15 CORNEAL GRAFT REJECTION 2 0.0095
16 SCEDOSPORIUM INFECTION 6 0.0085
17 INFECTIVE TENOSYNOVITIS 2 0.0079
18 LEUKAEMOID REACTION 2 0.0077
19 PUNCTATE KERATITIS 7 0.0076
20 SENSITIVITY TO WEATHER CHANGE 40 0.0076
21 INJECTION SITE DISCOLOURATION 88 0.0070
22 CELLULITIS ORBITAL 4 0.0069
23 VENOUS INJURY 6 0.0064
24 CORTISOL INCREASED 4 0.0064
25 CAPILLARY FRAGILITY 3 0.0059
26 CUSHINGOID 18 0.0056
27 SARCOIDOSIS 26 0.0055
28 CORTISOL DECREASED 6 0.0052
29 CONGENITAL DIAPHRAGMATIC HERNIA 2 0.0051
30 EYE LASER SURGERY 3 0.0051
31 IRIDOCYCLITIS 16 0.0051
32 GENITAL ABSCESS 2 0.0050
33 BLOOD URIC ACID ABNORMAL 2 0.0049
34 INJECTION SITE BRUISING 390 0.0049
35 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 9 0.0048
36 PERIORBITAL PAIN 4 0.0047
37 GENITAL LESION 2 0.0047
38 CUTANEOUS SARCOIDOSIS 2 0.0046
39 INJECTION SITE EXFOLIATION 3 0.0045
40 HEPATIC ENZYME DECREASED 2 0.0045
41 BLOOD CREATINE PHOSPHOKINASE ABNORMAL 2 0.0044
42 ALLERGY TO ARTHROPOD STING 2 0.0044
43 DERMATOMYOSITIS 11 0.0043
44 THERAPEUTIC PROCEDURE 6 0.0043
45 ADRENAL NEOPLASM 2 0.0043
46 INFANTILE SPASMS 3 0.0041
47 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 3 0.0041
48 FOETAL GROWTH RESTRICTION 24 0.0039
49 CREATINE KINASE INCREASED 3 0.0039
50 SCLERITIS 6 0.0037
51 HYPOGLYCAEMIA NEONATAL 6 0.0037
52 HYPERTENSIVE EMERGENCY 4 0.0034
53 CATARACT SUBCAPSULAR 2 0.0033
54 NOCARDIOSIS 8 0.0031
55 EYE OPERATION 14 0.0030
56 HERPES OPHTHALMIC 4 0.0030
57 FEAR OF INJECTION 21 0.0029
58 CUTANEOUS SYMPTOM 2 0.0029
59 FLUID RETENTION 146 0.0029
60 DELAYED GRAFT FUNCTION 2 0.0028
61 INCREASED TENDENCY TO BRUISE 25 0.0027
62 INCREASED APPETITE 51 0.0027
63 OPTIC NERVE INJURY 3 0.0026
64 MAGNETIC RESONANCE IMAGING ABNORMAL 3 0.0025
65 HEAT EXHAUSTION 2 0.0025
66 ALLERGIC GRANULOMATOUS ANGIITIS 2 0.0024
67 BRAIN FOG 38 0.0024
68 NASAL PRURITUS 3 0.0024
69 PERIPHERAL SENSORIMOTOR NEUROPATHY 3 0.0024
70 HYPERAESTHESIA TEETH 3 0.0024
71 GLIOBLASTOMA MULTIFORME 2 0.0024
72 ENDOCRINE OPHTHALMOPATHY 2 0.0023
73 CYSTOCELE 2 0.0023
74 CORNEAL DISORDER 5 0.0023
75 INJECTION SITE PRURITUS 148 0.0022
76 PRECANCEROUS CELLS PRESENT 3 0.0021
77 VASCULAR INJURY 3 0.0021
78 INJECTION SITE SCAB 2 0.0021
79 ANIMAL SCRATCH 2 0.0021
80 RED BLOOD CELL COUNT ABNORMAL 3 0.0020
81 ARTHRODESIS 2 0.0020
82 OPHTHALMOPLEGIA 3 0.0019
83 CARPAL TUNNEL DECOMPRESSION 2 0.0019
84 EAR SWELLING 4 0.0019
85 PROTEIN TOTAL INCREASED 5 0.0019
86 ALLERGY TO ANIMAL 2 0.0019
87 GLUCOSE TOLERANCE IMPAIRED 11 0.0019
88 FRUSTRATION TOLERANCE DECREASED 15 0.0019
89 HORDEOLUM 8 0.0018
90 CLAUSTROPHOBIA 2 0.0018
91 SHOULDER FRACTURE 3 0.0018
92 COLONOSCOPY 4 0.0018
93 JOINT LOCK 5 0.0018
94 INJECTION SITE SCAR 5 0.0018
95 SKIN HYPERPIGMENTATION 15 0.0017
96 TRIGEMINAL NEURALGIA 7 0.0017
97 NERVE COMPRESSION 16 0.0017
98 INJECTION SITE MASS 64 0.0017
99 NECK SURGERY 4 0.0017
100 AUTONOMIC NERVOUS SYSTEM IMBALANCE 5 0.0017
101 FOOD CRAVING 9 0.0017
102 DRUG WITHDRAWAL CONVULSIONS 3 0.0017
103 EYELID SKIN DRYNESS 2 0.0016
104 INJECTION SITE IRRITATION 21 0.0016
105 CARTILAGE INJURY 4 0.0016
106 AURA 3 0.0016
107 EYE INFECTION 18 0.0016
108 VASODILATATION 4 0.0016
109 MULTIPLE SCLEROSIS RELAPSE 106 0.0015
110 INJECTION SITE HAEMORRHAGE 123 0.0015
111 ABDOMINAL OPERATION 2 0.0015
112 FEELINGS OF WORTHLESSNESS 2 0.0015
113 JOINT NOISE 3 0.0015
114 BLOOD POTASSIUM ABNORMAL 4 0.0015
115 CONTRAINDICATED PRODUCT ADMINISTERED 45 0.0015
116 EYELID PAIN 3 0.0015
117 HICCUPS 12 0.0015
118 ULCERATIVE KERATITIS 4 0.0015
119 CORNEAL ABRASION 2 0.0015
120 NEPHROTIC SYNDROME 10 0.0015
121 ASTHENOPIA 8 0.0015
122 JOINT INSTABILITY 2 0.0014
123 NEUROGENIC BLADDER 3 0.0014
124 ANTICONVULSANT DRUG LEVEL DECREASED 2 0.0014
125 SEASONAL ALLERGY 20 0.0014
126 CONNECTIVE TISSUE DISORDER 2 0.0014
127 SHOULDER OPERATION 6 0.0014
128 INJECTION SITE HYPOAESTHESIA 2 0.0014
129 ESCHERICHIA SEPSIS 4 0.0014
130 INJECTION SITE SWELLING 104 0.0014
131 SYSTEMIC LUPUS ERYTHEMATOSUS 48 0.0014
132 INJECTION SITE URTICARIA 33 0.0013
133 ASTIGMATISM 2 0.0013
134 URINE ABNORMALITY 6 0.0013
135 ADRENAL INSUFFICIENCY 16 0.0013
136 KERATITIS 4 0.0013
137 INJECTION SITE PARAESTHESIA 2 0.0013
138 EYE ALLERGY 2 0.0013
139 URINARY HESITATION 3 0.0013
140 OXYGEN CONSUMPTION INCREASED 3 0.0013
141 SWELLING 117 0.0012
142 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2 0.0012
143 CYSTITIS INTERSTITIAL 2 0.0012
144 PERONEAL NERVE PALSY 7 0.0012
145 HORMONE LEVEL ABNORMAL 6 0.0012
146 RETINAL TEAR 3 0.0012
147 ILLNESS 125 0.0012
148 BLOOD IMMUNOGLOBULIN G DECREASED 3 0.0012
149 PRODUCT DOSE OMISSION IN ERROR 34 0.0012
150 GASTRIC DILATATION 2 0.0012
151 EXPOSURE TO SARS-COV-2 2 0.0012
152 ABNORMAL SENSATION IN EYE 5 0.0012
153 THERAPY NON-RESPONDER 52 0.0012
154 PRODUCT DOSE OMISSION ISSUE 339 0.0012
155 LACK OF INJECTION SITE ROTATION 2 0.0011
156 SPINAL OPERATION 14 0.0011
157 PERIPHERAL SWELLING 174 0.0011
158 INTRA-ABDOMINAL FLUID COLLECTION 2 0.0011
159 BLOOD PRESSURE ABNORMAL 22 0.0011
160 MUSCLE ATROPHY 14 0.0011
161 BLOOD POTASSIUM DECREASED 33 0.0011
162 ABDOMINAL HERNIA 5 0.0011
163 RED BLOOD CELL COUNT INCREASED 3 0.0011
164 HUNGER 15 0.0011
165 MASS 15 0.0011
166 INJECTION SITE WARMTH 22 0.0011
167 INJECTION SITE ERYTHEMA 132 0.0011
168 PROTEIN TOTAL DECREASED 4 0.0011
169 IMMUNE SYSTEM DISORDER 14 0.0011
170 APPETITE DISORDER 7 0.0011
171 FEELING JITTERY 20 0.0010
172 EYE INFLAMMATION 10 0.0010
173 LIMB DISCOMFORT 32 0.0010
174 INJECTION SITE PAIN 315 0.0010
175 ADRENOCORTICAL INSUFFICIENCY ACUTE 2 0.0010
176 INSOMNIA 273 0.0010
177 INTRAOCULAR PRESSURE INCREASED 13 0.0010
178 INJECTION SITE RASH 31 0.0010
179 INFLAMMATORY MARKER INCREASED 5 0.0010
180 HYPERPHAGIA 4 0.0010
181 SYMPTOM RECURRENCE 6 0.0010
182 CARDIAC DISCOMFORT 2 0.0010
183 OPTIC NEURITIS 9 0.0010
184 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 2 0.0010
185 RETINAL DETACHMENT 9 0.0010
186 CHEST INJURY 2 0.0010
187 BODY TEMPERATURE FLUCTUATION 2 0.0010
188 UVEITIS 13 0.0010
189 WEIGHT INCREASED 214 0.0010
190 SWELLING FACE 62 0.0010
191 EYE CONTUSION 2 0.0009
192 THERAPEUTIC RESPONSE SHORTENED 31 0.0009
193 BLOOD GLUCOSE INCREASED 176 0.0009
194 CARDIAC FLUTTER 6 0.0009
195 OSTEOPENIA 14 0.0009
196 INFUSION SITE HAEMORRHAGE 3 0.0009
197 BIPOLAR I DISORDER 2 0.0009
198 SKIN INJURY 3 0.0009
199 CYTOMEGALOVIRUS VIRAEMIA 4 0.0009
200 RHEUMATOID ARTHRITIS 102 0.0009
201 TASTE DISORDER 18 0.0009
202 EYE PAIN 50 0.0009
203 PERIORBITAL SWELLING 5 0.0009
204 TOOTH EXTRACTION 11 0.0009
205 GINGIVAL PAIN 7 0.0009
206 BRAIN OPERATION 2 0.0009
207 LEFT VENTRICULAR FAILURE 3 0.0009
208 JOINT EFFUSION 6 0.0009
209 SKIN ATROPHY 5 0.0009
210 EYE DISCHARGE 9 0.0009
211 APHONIA 12 0.0009
212 INGROWING NAIL 2 0.0008
213 BLOOD PRESSURE INCREASED 129 0.0008
214 SINUS HEADACHE 5 0.0008
215 SKIN WEEPING 3 0.0008
216 RENAL TRANSPLANT 3 0.0008
217 SKIN LACERATION 9 0.0008
218 INJECTION SITE VESICLES 5 0.0008
219 SPONDYLITIS 3 0.0008
220 HAEMATOLOGICAL INFECTION 2 0.0008
221 VITREOUS FLOATERS 8 0.0008
222 CEREBRAL DISORDER 6 0.0008
223 DENTAL OPERATION 2 0.0008
224 HYPERVOLAEMIA 4 0.0008
225 SINUS DISORDER 16 0.0008
226 DEVICE INFUSION ISSUE 2 0.0008
227 INFUSION SITE EXTRAVASATION 5 0.0008
228 INFREQUENT BOWEL MOVEMENTS 2 0.0008
229 PROTEIN URINE PRESENT 4 0.0008
230 DRY EYE 40 0.0008
231 BACK DISORDER 13 0.0008
232 VEIN DISORDER 4 0.0008
233 HYPERPARATHYROIDISM SECONDARY 2 0.0008
234 FACE INJURY 3 0.0008
235 CARPAL TUNNEL SYNDROME 11 0.0008
236 UNDERDOSE 57 0.0008
237 OESOPHAGEAL DISORDER 3 0.0008
238 TEMPERATURE INTOLERANCE 8 0.0008
239 INJECTION SITE INDURATION 10 0.0008
240 RHINOVIRUS INFECTION 3 0.0008
241 EPIGASTRIC DISCOMFORT 3 0.0008
242 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 138 0.0008
243 PROSTATOMEGALY 3 0.0008
244 MOOD SWINGS 24 0.0008
245 FUNGAL SKIN INFECTION 3 0.0007
246 SPINAL FUSION SURGERY 3 0.0007
247 HIP SURGERY 4 0.0007
248 CATARACT 44 0.0007
249 ULCER HAEMORRHAGE 5 0.0007
250 IMMUNODEFICIENCY 11 0.0007
251 CLUMSINESS 2 0.0007
252 DEMYELINATION 3 0.0007
253 SUPRAVENTRICULAR TACHYCARDIA 7 0.0007
254 CENTRAL NERVOUS SYSTEM LESION 10 0.0007
255 GENERALISED OEDEMA 9 0.0007
256 SPINAL STENOSIS 3 0.0007
257 EAR PAIN 14 0.0007
258 GASTROENTERITIS VIRAL 13 0.0007
259 HEART RATE ABNORMAL 4 0.0007
260 CONDITION AGGRAVATED 217 0.0007
261 ENDOTRACHEAL INTUBATION 2 0.0007
262 GLYCOSYLATED HAEMOGLOBIN INCREASED 18 0.0007
263 DRUG TOLERANCE DECREASED 2 0.0007
264 MUSCLE FATIGUE 3 0.0007
265 ESCHERICHIA URINARY TRACT INFECTION 3 0.0007
266 HAND FRACTURE 5 0.0007
267 ABSCESS LIMB 3 0.0007
268 BLOOD GLUCOSE ABNORMAL 13 0.0007
269 VITAMIN D DECREASED 6 0.0007
270 IRRITABILITY 42 0.0007
271 MUSCULAR WEAKNESS 79 0.0007
272 MUSCLE STRAIN 6 0.0007
273 EYELID MARGIN CRUSTING 2 0.0007
274 BONE CANCER 3 0.0007
275 HYPERTENSION 146 0.0007
276 SKIN WARM 4 0.0007
277 ONYCHOMYCOSIS 3 0.0007
278 ABDOMINAL ABSCESS 3 0.0007
279 LABORATORY TEST ABNORMAL 20 0.0007
280 BLOOD IRON DECREASED 8 0.0007
281 PLEURISY 4 0.0007
282 THIRST 12 0.0007
283 INJECTION SITE DISCOMFORT 7 0.0007
284 CONTUSION 64 0.0007
285 SUSPECTED OFF LABEL USE 3 0.0007
286 EYE INJURY 2 0.0007
287 THERAPEUTIC PRODUCT EFFECT DELAYED 3 0.0007
288 TENSION 4 0.0007
289 HIP ARTHROPLASTY 10 0.0007
290 BOWEL MOVEMENT IRREGULARITY 5 0.0007
291 ISCHAEMIA 3 0.0007
292 POOR QUALITY SLEEP 14 0.0006
293 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
294 PHARYNGITIS STREPTOCOCCAL 7 0.0006
295 BLOOD BLISTER 2 0.0006
296 SKIN DISCOLOURATION 29 0.0006
297 BLADDER PAIN 2 0.0006
298 FOREIGN BODY SENSATION IN EYES 4 0.0006
299 SCIATICA 10 0.0006
300 LIMB INJURY 17 0.0006
301 LIMB OPERATION 3 0.0006
302 SNEEZING 14 0.0006
303 OCULAR DISCOMFORT 7 0.0006
304 AFFECT LABILITY 6 0.0006
305 ROTATOR CUFF SYNDROME 8 0.0006
306 HEAD DISCOMFORT 11 0.0006
307 DIZZINESS POSTURAL 6 0.0006
308 EYE SWELLING 23 0.0006
309 ANTINUCLEAR ANTIBODY POSITIVE 2 0.0006
310 PHARYNGEAL SWELLING 6 0.0006
311 HEPATIC NEOPLASM 2 0.0006
312 OEDEMA 33 0.0006
313 DYSGRAPHIA 4 0.0006
314 WALKING AID USER 4 0.0006
315 FATIGUE 469 0.0006
316 VIRAL INFECTION 20 0.0006
317 DERMATITIS EXFOLIATIVE 3 0.0006
318 EYE HAEMORRHAGE 8 0.0006
319 SKIN MASS 4 0.0006
320 ABDOMINAL DISTENSION 62 0.0006
321 CANDIDA INFECTION 10 0.0006
322 THINKING ABNORMAL 11 0.0006
323 DIABETIC RETINOPATHY 2 0.0006
324 EYE MOVEMENT DISORDER 4 0.0006
325 INTERNATIONAL NORMALISED RATIO ABNORMAL 2 0.0006
326 SURGERY 34 0.0006
327 BLOOD MAGNESIUM DECREASED 5 0.0006
328 HAIR GROWTH ABNORMAL 4 0.0006
329 EYE DISORDER 19 0.0006
330 FAILURE TO THRIVE 3 0.0006
331 GRANULOMA 2 0.0006
332 NEURALGIA 14 0.0006
333 BALANCE DISORDER 49 0.0006
334 NEPHROLITHIASIS 26 0.0006
335 PSORIATIC ARTHROPATHY 23 0.0006
336 CYSTITIS 18 0.0006
337 LACRIMATION INCREASED 17 0.0006
338 AGEUSIA 14 0.0006
339 APPENDICECTOMY 2 0.0006
340 FOOD POISONING 3 0.0006
341 OVERWEIGHT 3 0.0006
342 VISUAL IMPAIRMENT 69 0.0006
343 GINGIVITIS 3 0.0006
344 ANAL INCONTINENCE 5 0.0006
345 BIPOLAR DISORDER 6 0.0006
346 POLLAKIURIA 23 0.0006
347 EXOSTOSIS 5 0.0005
348 WHITE BLOOD CELL COUNT INCREASED 21 0.0005
349 HEART RATE INCREASED 54 0.0005
350 TOOTH FRACTURE 6 0.0005
351 PROSTATIC DISORDER 3 0.0005
352 UROSEPSIS 5 0.0005
353 INJECTION SITE INJURY 3 0.0005
354 UPPER RESPIRATORY TRACT INFECTION 25 0.0005
355 NERVE INJURY 6 0.0005
356 JOINT SWELLING 65 0.0005
357 PHOTOPHOBIA 10 0.0005
358 VISION BLURRED 73 0.0005
359 HEMIPARESIS 9 0.0005
360 ARTERIOSCLEROSIS 5 0.0005
361 ADVERSE REACTION 7 0.0005
362 OCULAR HYPERAEMIA 25 0.0005
363 EAR INFECTION 14 0.0005
364 MICTURITION URGENCY 6 0.0005
365 SLEEP APNOEA SYNDROME 10 0.0005
366 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
367 HYPERSOMNIA 15 0.0005
368 HEADACHE 328 0.0005
369 MUSCULOSKELETAL DISCOMFORT 9 0.0005
370 GASTRIC INFECTION 2 0.0005
371 GINGIVAL DISORDER 2 0.0005
372 THYROID DISORDER 8 0.0005
373 ANKLE FRACTURE 8 0.0005
374 CONCUSSION 4 0.0005
375 ASTHENIA 194 0.0005
376 APHTHOUS ULCER 4 0.0005
377 VITAMIN D DEFICIENCY 5 0.0005
378 GASTROINTESTINAL INFLAMMATION 4 0.0005
379 RHINORRHOEA 33 0.0005
380 HYPERCHLORHYDRIA 3 0.0005
381 SINUSITIS 52 0.0005
382 CATARACT OPERATION 3 0.0005
383 FEELING ABNORMAL 121 0.0005
384 INFLAMMATION 26 0.0005
385 RENAL CYST 4 0.0005
386 ACCIDENT 6 0.0005
387 NECK PAIN 28 0.0005
388 TINNITUS 23 0.0005
389 MEMORY IMPAIRMENT 68 0.0005
390 GALLBLADDER OPERATION 2 0.0005
391 FIBROMYALGIA 12 0.0005
392 BLINDNESS 20 0.0005
393 NEUTROPHIL COUNT INCREASED 5 0.0005
394 MENISCUS INJURY 3 0.0005
395 OSTEOPOROSIS 20 0.0005
396 PIGMENTATION DISORDER 3 0.0005
397 HEPATIC STEATOSIS 9 0.0005
398 HEMIPLEGIA 4 0.0005
399 EOSINOPHIL COUNT INCREASED 4 0.0005
400 WEIGHT FLUCTUATION 5 0.0005
401 SWELLING OF EYELID 3 0.0005
402 SCRATCH 5 0.0005
403 PROTEINURIA 9 0.0005
404 JOINT DISLOCATION 5 0.0005
405 GASTROOESOPHAGEAL REFLUX DISEASE 38 0.0005
406 PULMONARY MASS 7 0.0005
407 CARDIAC FAILURE CHRONIC 2 0.0005
408 JOINT INJURY 10 0.0005
409 IRRITABLE BOWEL SYNDROME 10 0.0005
410 INFLUENZA 52 0.0005
411 HIATUS HERNIA 6 0.0005
412 HEPATIC LESION 2 0.0005
413 MULTIPLE SCLEROSIS 22 0.0005
414 BACK INJURY 5 0.0005
415 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
416 PULMONARY THROMBOSIS 5 0.0005
417 INSURANCE ISSUE 7 0.0005
418 DYSPHEMIA 2 0.0005
419 NASOPHARYNGITIS 84 0.0005
420 LOCALISED INFECTION 11 0.0005
421 HYPOGLYCAEMIA 22 0.0005
422 IMMUNOSUPPRESSION 4 0.0005
423 GINGIVAL SWELLING 2 0.0005
424 MIGRAINE 43 0.0004
425 MENINGITIS 3 0.0004
426 FALL 149 0.0004
427 POST-TRAUMATIC STRESS DISORDER 3 0.0004
428 BRAIN NEOPLASM MALIGNANT 2 0.0004
429 GASTROINTESTINAL INFECTION 4 0.0004
430 DIABETES MELLITUS 34 0.0004
431 MYOSITIS 4 0.0004
432 HEAVY MENSTRUAL BLEEDING 4 0.0004
433 DYSPHONIA 26 0.0004
434 OROPHARYNGEAL DISCOMFORT 4 0.0004
435 HEAD INJURY 14 0.0004
436 DISEASE RECURRENCE 21 0.0004
437 IMPAIRED GASTRIC EMPTYING 6 0.0004
438 IMPAIRED DRIVING ABILITY 5 0.0004
439 SLEEP DISORDER 31 0.0004
440 BLOOD TESTOSTERONE DECREASED 3 0.0004
441 PERIPHERAL COLDNESS 6 0.0004
442 BRONCHITIS 32 0.0004
443 ORAL DISCOMFORT 6 0.0004
444 CONJUNCTIVITIS 8 0.0004
445 ARTHRITIS INFECTIVE 2 0.0004
446 COORDINATION ABNORMAL 6 0.0004
447 THERAPY CESSATION 22 0.0004
448 APPENDICITIS 4 0.0004
449 BURNING SENSATION 30 0.0004
450 NASAL CONGESTION 25 0.0004
451 BLINDNESS UNILATERAL 6 0.0004
452 MUSCLE SPASMS 78 0.0004
453 DYSPNOEA EXERTIONAL 16 0.0004
454 THERMAL BURN 3 0.0004
455 SPINAL DISORDER 4 0.0004
456 SPUTUM DISCOLOURED 4 0.0004
457 ATAXIA 5 0.0004
458 CARDIAC TAMPONADE 2 0.0004
459 ARTHRITIS 33 0.0004
460 JOINT STIFFNESS 11 0.0004
461 PARALYSIS 6 0.0004
462 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 4 0.0004
463 PALPITATIONS 49 0.0004
464 HERPES ZOSTER 24 0.0004
465 PARAESTHESIA ORAL 6 0.0004
466 TREMOR 69 0.0004
467 APHAGIA 2 0.0004
468 FAECES DISCOLOURED 9 0.0004
469 HERNIA 8 0.0004
470 NOCTURIA 5 0.0004
471 INTERVERTEBRAL DISC PROTRUSION 9 0.0004
472 ABDOMINAL DISCOMFORT 69 0.0004
473 UTERINE LEIOMYOMA 3 0.0004
474 AUTOIMMUNE DISORDER 4 0.0004
475 CHEST DISCOMFORT 42 0.0004
476 CHOKING 8 0.0004
477 ORAL DISORDER 3 0.0004
478 SCAR 7 0.0004
479 FEELING HOT 25 0.0004
480 MUSCLE SPASTICITY 5 0.0004
481 BLINDNESS TRANSIENT 3 0.0004
482 SENSITIVE SKIN 3 0.0004
483 KNEE OPERATION 4 0.0004
484 URINARY INCONTINENCE 12 0.0004
485 TENDON RUPTURE 5 0.0004
486 ARTHROPOD BITE 3 0.0004
487 FOOT OPERATION 2 0.0004
488 MOOD ALTERED 11 0.0004
489 SUNBURN 3 0.0004
490 HEPATIC ENZYME ABNORMAL 2 0.0004
491 INFLUENZA LIKE ILLNESS 33 0.0004
492 HYDRONEPHROSIS 3 0.0004
493 DRUG TOLERANCE 2 0.0004
494 DRY THROAT 4 0.0004
495 MOTOR DYSFUNCTION 4 0.0004
496 SOMNOLENCE 79 0.0004
497 SLUGGISHNESS 4 0.0004
498 GAIT DISTURBANCE 75 0.0004
499 LIP SWELLING 13 0.0004
500 GOUT 7 0.0004
501 FUNGAL INFECTION 13 0.0004
502 INITIAL INSOMNIA 4 0.0004
503 ADVERSE DRUG REACTION 35 0.0004
504 URINARY RETENTION 13 0.0004
505 SEIZURE 45 0.0004
506 URINARY TRACT INFECTION 66 0.0004
507 DIPLOPIA 10 0.0004
508 BONE DISORDER 7 0.0004
509 NERVOUSNESS 20 0.0004
510 DRY MOUTH 31 0.0004
511 AFFECTIVE DISORDER 3 0.0004
512 PAIN 234 0.0004
513 KNEE ARTHROPLASTY 8 0.0004
514 FURUNCLE 3 0.0004
515 PNEUMOTHORAX 6 0.0004
516 OROPHARYNGEAL PAIN 35 0.0004
517 VERTIGO 23 0.0004
518 ULCER 6 0.0004
519 HYPOAESTHESIA 56 0.0004
520 BODY HEIGHT DECREASED 4 0.0004
521 COMPRESSION FRACTURE 2 0.0004
522 HYPERSENSITIVITY 69 0.0004
523 BLOOD SODIUM DECREASED 7 0.0004
524 HEART RATE DECREASED 13 0.0004
525 SINUS CONGESTION 5 0.0004
526 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
527 POLYURIA 3 0.0004
528 ASPIRATION 4 0.0004
529 POST PROCEDURAL COMPLICATION 7 0.0004
530 APHASIA 11 0.0004
531 GLAUCOMA 7 0.0004
532 HYPERKERATOSIS 2 0.0004
533 BLOOD PRESSURE DECREASED 24 0.0004
534 FEELING COLD 10 0.0004
535 GAIT INABILITY 12 0.0004
536 ORAL HERPES 7 0.0004
537 HOSPITALISATION 55 0.0004
538 ANGIOPATHY 2 0.0004
539 KIDNEY INFECTION 7 0.0004
540 PANIC ATTACK 13 0.0004
541 SKIN INFECTION 4 0.0004
542 PAIN IN EXTREMITY 105 0.0004
543 ARTHRALGIA 148 0.0004
544 BLOOD CALCIUM DECREASED 4 0.0004
545 COLECTOMY 2 0.0004
546 ABDOMINAL PAIN UPPER 72 0.0003
547 SPINAL FRACTURE 7 0.0003
548 CARDIAC OPERATION 3 0.0003
549 MOBILITY DECREASED 25 0.0003
550 LETHARGY 20 0.0003
551 ENTEROCOLITIS 2 0.0003
552 HYSTERECTOMY 3 0.0003
553 PYELONEPHRITIS 3 0.0003
554 DYSPEPSIA 34 0.0003
555 COMPLICATION ASSOCIATED WITH DEVICE 5 0.0003
556 DEAFNESS 9 0.0003
557 NAIL DISORDER 3 0.0003
558 HYPERKALAEMIA 12 0.0003
559 GROIN PAIN 3 0.0003
560 FACIAL PAIN 3 0.0003
561 CARDIAC PACEMAKER INSERTION 2 0.0003
562 PRODUCTIVE COUGH 16 0.0003
563 PULMONARY OEDEMA 15 0.0003
564 THERAPEUTIC PRODUCT EFFECT DECREASED 15 0.0003
565 STAPHYLOCOCCAL INFECTION 11 0.0003
566 BLOOD PRESSURE FLUCTUATION 8 0.0003
567 HOT FLUSH 25 0.0003
568 HYPOAESTHESIA ORAL 5 0.0003
569 BACK PAIN 76 0.0003
570 COUGH 91 0.0003
571 DIZZINESS 161 0.0003
572 CHOLANGITIS 2 0.0003
573 WOUND 9 0.0003
574 COGNITIVE DISORDER 15 0.0003
575 THERAPY PARTIAL RESPONDER 5 0.0003
576 FLANK PAIN 3 0.0003
577 WEIGHT DECREASED 89 0.0003
578 INFUSION SITE SWELLING 2 0.0003
579 CELLULITIS 16 0.0003
580 BRAIN OEDEMA 4 0.0003
581 FOOT FRACTURE 6 0.0003
582 BLOOD URINE PRESENT 6 0.0003
583 GASTRIC ULCER 6 0.0003
584 FLUSHING 32 0.0003
585 PULMONARY FIBROSIS 6 0.0003
586 ORAL PAIN 7 0.0003
587 THROAT IRRITATION 14 0.0003
588 INFECTION 45 0.0003
589 WITHDRAWAL SYNDROME 13 0.0003
590 DYSGEUSIA 23 0.0003
591 INCOHERENT 2 0.0003
592 BLOOD POTASSIUM INCREASED 5 0.0003
593 FOETAL EXPOSURE DURING PREGNANCY 25 0.0003
594 NODULE 4 0.0003
595 SEPSIS 34 0.0003
596 BODY TEMPERATURE DECREASED 3 0.0003
597 ANKYLOSING SPONDYLITIS 4 0.0003
598 TOOTH INFECTION 4 0.0003
599 DISABILITY 6 0.0003
600 MALAISE 133 0.0003
601 PHOTOSENSITIVITY REACTION 5 0.0003
602 PERICARDIAL EFFUSION 7 0.0003
603 CRYING 11 0.0003
604 HAEMATOCRIT DECREASED 6 0.0003
605 BLADDER DISORDER 3 0.0003
606 PSYCHOMOTOR HYPERACTIVITY 5 0.0003
607 UPPER LIMB FRACTURE 6 0.0003
608 RESPIRATORY DISORDER 9 0.0003
609 BLOOD CHOLESTEROL INCREASED 14 0.0003
610 QUALITY OF LIFE DECREASED 4 0.0003
611 CONSTIPATION 65 0.0003
612 BREAST MASS 2 0.0003
613 EYE PRURITUS 10 0.0003
614 TRANSIENT ISCHAEMIC ATTACK 10 0.0003
615 FEEDING DISORDER 6 0.0003
616 EYE IRRITATION 17 0.0003
617 EYELID PTOSIS 3 0.0003
618 EUPHORIC MOOD 3 0.0003
619 EAR DISCOMFORT 3 0.0003
620 PRODUCT PREPARATION ERROR 6 0.0003
621 ANXIETY 83 0.0003
622 COVID-19 51 0.0003
623 SKELETAL INJURY 3 0.0003
624 LARGE INTESTINE POLYP 2 0.0003
625 DIVERTICULITIS 8 0.0003
626 PULMONARY HYPERTENSION 6 0.0003
627 PNEUMONIA 93 0.0003
628 LOCAL SWELLING 5 0.0003
629 EXTRASYSTOLES 2 0.0003
630 ALOPECIA 56 0.0003
631 DEPRESSED MOOD 15 0.0003
632 FULL BLOOD COUNT ABNORMAL 3 0.0003
633 ABASIA 7 0.0003
634 OSTEOARTHRITIS 12 0.0003
635 LYMPHOCYTE COUNT DECREASED 5 0.0003
636 DIALYSIS 4 0.0003
637 RED BLOOD CELL COUNT DECREASED 8 0.0003
638 DISCOMFORT 17 0.0003
639 IMPAIRED QUALITY OF LIFE 4 0.0003
640 DECREASED ACTIVITY 3 0.0003
641 WHITE BLOOD CELL COUNT DECREASED 30 0.0003
642 INJECTION SITE REACTION 19 0.0003
643 INJECTION SITE HAEMATOMA 4 0.0003
644 PRODUCT USE IN UNAPPROVED INDICATION 68 0.0003
645 IMPAIRED HEALING 9 0.0003
646 DYSSTASIA 8 0.0003
647 THROMBOSIS 22 0.0003
648 CHILLS 32 0.0003
649 BLOOD GLUCOSE DECREASED 13 0.0003
650 FOOT DEFORMITY 3 0.0003
651 TOOTH DISORDER 6 0.0003
652 HYPERTENSIVE CRISIS 3 0.0003
653 RESPIRATORY TRACT INFECTION 7 0.0003
654 EPISTAXIS 20 0.0003
655 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 19 0.0003
656 BLISTER 15 0.0003
657 GENERAL SYMPTOM 2 0.0003
658 HYPERHIDROSIS 34 0.0003
659 ACNE 20 0.0003
660 DERMATITIS CONTACT 3 0.0003
661 MUSCULOSKELETAL DISORDER 5 0.0003
662 MUSCULOSKELETAL STIFFNESS 23 0.0003
663 MENSTRUATION IRREGULAR 7 0.0003
664 PARAESTHESIA 41 0.0003
665 MUSCLE TWITCHING 6 0.0003
666 DEPRESSION 59 0.0003
667 ATRIOVENTRICULAR BLOCK 2 0.0003
668 TENDONITIS 4 0.0003
669 RASH PRURITIC 14 0.0003
670 ELECTROLYTE IMBALANCE 3 0.0003
671 POST PROCEDURAL HAEMORRHAGE 3 0.0003
672 RENAL DISORDER 12 0.0003
673 LUNG INFECTION 4 0.0003
674 APNOEA 2 0.0003
675 GASTROINTESTINAL DISORDER 23 0.0003
676 BASAL CELL CARCINOMA 4 0.0003
677 SWOLLEN TONGUE 8 0.0003
678 SPINAL PAIN 3 0.0003
679 SKIN FISSURES 5 0.0003
680 DEHYDRATION 34 0.0003
681 COVID-19 PNEUMONIA 3 0.0003
682 NEUROPATHY PERIPHERAL 24 0.0003
683 BLOOD ALBUMIN DECREASED 2 0.0003
684 CHOLECYSTITIS 3 0.0003
685 RESPIRATORY TRACT CONGESTION 4 0.0003
686 URTICARIA 42 0.0003
687 ATRIAL FLUTTER 2 0.0003
688 RASH 109 0.0002
689 DIARRHOEA 161 0.0002
690 ERYTHEMA 51 0.0002
691 PRODUCT ADMINISTRATION ERROR 5 0.0002
692 MUSCLE TIGHTNESS 4 0.0002
693 PRESYNCOPE 6 0.0002
694 DECUBITUS ULCER 2 0.0002
695 BODY TEMPERATURE INCREASED 5 0.0002
696 DYSURIA 9 0.0002
697 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
698 HYPERAESTHESIA 2 0.0002
699 ESCHERICHIA INFECTION 2 0.0002
700 HAIR DISORDER 2 0.0002
701 DYSPHAGIA 23 0.0002
702 PRURITUS 92 0.0002
703 ADVERSE EVENT 22 0.0002
704 RENAL IMPAIRMENT 20 0.0002
705 FACE OEDEMA 4 0.0002
706 DYSPNOEA 134 0.0002
707 ANGER 8 0.0002
708 CARDIAC DISORDER 22 0.0002
709 NAUSEA 185 0.0002
710 HYPOACUSIS 10 0.0002
711 SKIN CANCER 5 0.0002
712 SKIN ULCER 6 0.0002
713 CARDIAC MURMUR 2 0.0002
714 ILL-DEFINED DISORDER 14 0.0002
715 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 11 0.0002
716 BLOOD CALCIUM INCREASED 2 0.0002
717 LYMPHADENOPATHY 8 0.0002
718 HAIR TEXTURE ABNORMAL 3 0.0002
719 MALIGNANT MELANOMA 3 0.0002
720 THERAPEUTIC RESPONSE UNEXPECTED 10 0.0002
721 DISTURBANCE IN ATTENTION 12 0.0002
722 HEART RATE IRREGULAR 5 0.0002
723 TOOTHACHE 4 0.0002
724 PELVIC PAIN 4 0.0002
725 RESTLESS LEGS SYNDROME 4 0.0002
726 HYPERGLYCAEMIA 8 0.0002
727 RESTLESSNESS 8 0.0002
728 PROSTATIC SPECIFIC ANTIGEN INCREASED 3 0.0002
729 NIGHT SWEATS 7 0.0002
730 IRON DEFICIENCY ANAEMIA 2 0.0002
731 AMNESIA 14 0.0002
732 ROAD TRAFFIC ACCIDENT 9 0.0002
733 PRODUCT DOSE OMISSION 14 0.0002
734 BLOOD CREATININE INCREASED 14 0.0002
735 BACTERIAL INFECTION 4 0.0002
736 HYPOTENSION 43 0.0002
737 STOMATITIS 13 0.0002
738 DIARRHOEA HAEMORRHAGIC 2 0.0002
739 OXYGEN SATURATION DECREASED 12 0.0002
740 CARDIAC FAILURE CONGESTIVE 17 0.0002
741 HYPOCALCAEMIA 4 0.0002
742 SINUS TACHYCARDIA 3 0.0002
743 COLITIS 8 0.0002
744 INTENTIONAL DOSE OMISSION 6 0.0002
745 LOWER LIMB FRACTURE 4 0.0002
746 HYPERTHYROIDISM 3 0.0002
747 ATELECTASIS 2 0.0002
748 DECREASED APPETITE 48 0.0002
749 HYPOKINESIA 3 0.0002
750 MENTAL IMPAIRMENT 5 0.0002
751 ATRIAL FIBRILLATION 20 0.0002
752 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
753 OEDEMA PERIPHERAL 25 0.0002
754 COELIAC DISEASE 2 0.0002
755 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
756 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
757 SKIN HAEMORRHAGE 3 0.0002
758 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 41 0.0002
759 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 11 0.0002
760 RASH MACULAR 7 0.0002
761 MYALGIA 34 0.0002
762 SYNCOPE 20 0.0002
763 BONE LOSS 3 0.0002
764 BRAIN INJURY 2 0.0002
765 UNEVALUABLE EVENT 15 0.0002
766 CHRONIC KIDNEY DISEASE 15 0.0002
767 PHARYNGEAL OEDEMA 3 0.0002
768 DRUG RESISTANCE 5 0.0002
769 EMOTIONAL DISORDER 6 0.0002
770 HELICOBACTER INFECTION 2 0.0002
771 RIB FRACTURE 4 0.0002
772 FLATULENCE 11 0.0002
773 ANAPHYLACTIC SHOCK 5 0.0002
774 MUSCULOSKELETAL CHEST PAIN 3 0.0002
775 HYPERBILIRUBINAEMIA 2 0.0002
776 TOOTH LOSS 4 0.0002
777 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 10 0.0002
778 BONE DENSITY DECREASED 6 0.0002
779 TACHYCARDIA 17 0.0002
780 GASTRITIS 5 0.0002
781 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
782 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
783 RASH ERYTHEMATOUS 9 0.0002
784 HYPOTHYROIDISM 6 0.0002
785 EATING DISORDER 4 0.0002
786 LOSS OF CONSCIOUSNESS 24 0.0002
787 SENSORY DISTURBANCE 3 0.0002
788 MOVEMENT DISORDER 6 0.0002
789 LIVER FUNCTION TEST INCREASED 4 0.0002
790 WHEEZING 11 0.0002
791 PALLOR 5 0.0002
792 BLOOD GLUCOSE FLUCTUATION 2 0.0002
793 HAEMORRHAGE 19 0.0002
794 HAEMATOCHEZIA 10 0.0002
795 RESPIRATORY DISTRESS 5 0.0002
796 DENTAL CARIES 2 0.0002
797 MENTAL STATUS CHANGES 5 0.0002
798 SKIN DISORDER 6 0.0002
799 GLOSSODYNIA 4 0.0002
800 CHEST PAIN 33 0.0002
801 CEREBROVASCULAR ACCIDENT 30 0.0002
802 DISORIENTATION 7 0.0002
803 CHOLECYSTECTOMY 2 0.0002
804 INTERNAL HAEMORRHAGE 2 0.0002
805 ANGINA PECTORIS 5 0.0002
806 CONFUSIONAL STATE 28 0.0002
807 EYELID OEDEMA 2 0.0002
808 LIVER FUNCTION TEST ABNORMAL 5 0.0002
809 DEVICE MALFUNCTION 12 0.0002
810 PYREXIA 59 0.0002
811 HYPOXIA 6 0.0002
812 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
813 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
814 ARRHYTHMIA 8 0.0002
815 BACTERAEMIA 2 0.0002
816 ASTHMA 19 0.0002
817 DRUG INEFFECTIVE 221 0.0002
818 INFUSION RELATED REACTION 11 0.0002
819 OSTEOMYELITIS 3 0.0002
820 HAEMOGLOBIN DECREASED 17 0.0002
821 BURSITIS 2 0.0002
822 END STAGE RENAL DISEASE 3 0.0002
823 ENCEPHALOPATHY 4 0.0002
824 INJECTION SITE EXTRAVASATION 2 0.0002
825 CARDIAC FAILURE 13 0.0002
826 ARTHROPATHY 9 0.0002
827 CYST 2 0.0002
828 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
829 HALLUCINATION 12 0.0002
830 FRACTURE 3 0.0002
831 PRODUCT COMPLAINT 4 0.0002
832 VOMITING 74 0.0002
833 DRY SKIN 21 0.0002
834 HYPOPHAGIA 4 0.0002
835 HIP FRACTURE 5 0.0002
836 INFUSION SITE PAIN 2 0.0002
837 EXPOSURE VIA SKIN CONTACT 4 0.0002
838 THERAPY INTERRUPTED 11 0.0002
839 HAEMORRHOIDS 3 0.0002
840 PLASMA CELL MYELOMA 6 0.0002
841 ECZEMA 8 0.0002
842 SKIN IRRITATION 7 0.0002
843 MENORRHAGIA 3 0.0002
844 SPEECH DISORDER 8 0.0002
845 OSTEONECROSIS 5 0.0002
846 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
847 DYSMENORRHOEA 2 0.0002
848 EXPIRED PRODUCT ADMINISTERED 5 0.0002
849 INCORRECT DOSE ADMINISTERED 34 0.0001
850 FEAR 4 0.0001
851 PAIN OF SKIN 4 0.0001
852 THROAT TIGHTNESS 4 0.0001
853 PNEUMONITIS 4 0.0001
854 HAEMATURIA 5 0.0001
855 SKIN LESION 4 0.0001
856 DRUG INTOLERANCE 14 0.0001
857 PROCEDURAL PAIN 4 0.0001
858 HYPOMAGNESAEMIA 2 0.0001
859 HAEMOPTYSIS 4 0.0001
860 RENAL FAILURE 19 0.0001
861 LUNG DISORDER 7 0.0001
862 BLOOD TEST ABNORMAL 2 0.0001
863 DEVICE OCCLUSION 2 0.0001
864 DRUG DOSE OMISSION 23 0.0001
865 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
866 DEEP VEIN THROMBOSIS 9 0.0001
867 ANOSMIA 2 0.0001
868 PSORIASIS 18 0.0001
869 PRODUCT PRESCRIBING ISSUE 3 0.0001
870 FLUID OVERLOAD 2 0.0001
871 BONE PAIN 8 0.0001
872 APPLICATION SITE PAIN 3 0.0001
873 LIVER DISORDER 6 0.0001
874 HAEMORRHAGE INTRACRANIAL 2 0.0001
875 MUSCULOSKELETAL PAIN 7 0.0001
876 PANCREATITIS ACUTE 3 0.0001
877 CHROMATURIA 3 0.0001
878 DYSARTHRIA 5 0.0001
879 INTESTINAL OBSTRUCTION 5 0.0001
880 HEPATIC ENZYME INCREASED 9 0.0001
881 ECONOMIC PROBLEM 2 0.0001
882 EPILEPSY 4 0.0001
883 SHOCK 3 0.0001
884 ALANINE AMINOTRANSFERASE INCREASED 8 0.0001
885 DEVICE RELATED INFECTION 2 0.0001
886 CYANOSIS 2 0.0001
887 ANAEMIA 24 0.0001
888 ABSCESS 2 0.0001
889 AGITATION 9 0.0001
890 CARDIAC ARREST 10 0.0001
891 BLOOD UREA INCREASED 2 0.0001
892 TYPE 2 DIABETES MELLITUS 4 0.0001
893 UNRESPONSIVE TO STIMULI 3 0.0001
894 HAEMATOMA 3 0.0001
895 NIGHTMARE 4 0.0001
896 DEVICE DEFECTIVE 2 0.0001
897 DELIRIUM 4 0.0001
898 SEPTIC SHOCK 5 0.0001
899 MYOCARDIAL INFARCTION 20 0.0001
900 DERMATITIS ATOPIC 6 0.0001
901 DRUG INTERACTION 18 0.0001
902 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
903 MATERNAL EXPOSURE DURING PREGNANCY 10 0.0001
904 GALLBLADDER DISORDER 2 0.0001
905 COLITIS ULCERATIVE 5 0.0001
906 LOWER RESPIRATORY TRACT INFECTION 5 0.0001
907 ABNORMAL DREAMS 3 0.0001
908 PANCYTOPENIA 6 0.0001
909 DEMENTIA 3 0.0001
910 HEPATIC CIRRHOSIS 2 0.0001
911 PAIN IN JAW 3 0.0001
912 CONVULSION 6 0.0001
913 ACUTE RESPIRATORY FAILURE 2 0.0001
914 ERUCTATION 2 0.0001
915 DYSTONIA 2 0.0001
916 FULL BLOOD COUNT DECREASED 2 0.0001
917 INTENTIONAL SELF-INJURY 2 0.0001
918 ABDOMINAL PAIN 23 0.0001
919 EXTRA DOSE ADMINISTERED 4 0.0001
920 INJURY ASSOCIATED WITH DEVICE 2 0.0001
921 NEUTROPHIL COUNT DECREASED 4 0.0001
922 LUNG NEOPLASM MALIGNANT 4 0.0001
923 FEMUR FRACTURE 3 0.0001
924 RENAL FAILURE ACUTE 4 0.0001
925 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
926 PLATELET COUNT DECREASED 10 0.0001
927 IMPAIRED WORK ABILITY 2 0.0001
928 CHOLELITHIASIS 3 0.0001
929 INTENTIONAL PRODUCT USE ISSUE 8 0.0001
930 ANAPHYLACTIC REACTION 5 0.0001
931 PRODUCT USE ISSUE 17 0.0001
932 VISUAL ACUITY REDUCED 3 0.0001
933 HYPONATRAEMIA 5 0.0001
934 PRODUCT SUBSTITUTION ISSUE 5 0.0001
935 HYPOKALAEMIA 4 0.0001
936 GENERAL PHYSICAL HEALTH DETERIORATION 10 0.0001
937 PULMONARY EMBOLISM 8 0.0001
938 DRUG EFFECT INCOMPLETE 3 0.0001
939 THERAPEUTIC RESPONSE DECREASED 5 0.0001
940 PLEURAL EFFUSION 5 0.0001
941 OFF LABEL USE 71 0.0001
942 THROMBOCYTOPENIA 9 0.0001
943 LEUKOPENIA 4 0.0001
944 INTENTIONAL PRODUCT MISUSE 7 0.0001
945 ABNORMAL BEHAVIOUR 3 0.0001
946 NEOPLASM MALIGNANT 5 0.0001
947 BLOOD BILIRUBIN INCREASED 2 0.0001
948 FREQUENT BOWEL MOVEMENTS 2 0.0001
949 DEVICE BREAKAGE 3 0.0001
950 DYSKINESIA 3 0.0001
951 TREATMENT NONCOMPLIANCE 4 0.0001
952 CARDIO-RESPIRATORY ARREST 3 0.0001
953 SKIN EXFOLIATION 6 0.0001
954 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
955 VAGINAL HAEMORRHAGE 3 0.0001
956 MENTAL DISORDER 3 0.0001
957 RESPIRATORY FAILURE 5 0.0001
958 ACUTE MYOCARDIAL INFARCTION 2 0.0001
959 EMOTIONAL DISTRESS 8 0.0001
960 CORONARY ARTERY DISEASE 2 0.0001
961 ACUTE KIDNEY INJURY 10 0.0001
962 DRUG ADMINISTRATION ERROR 2 0.0001
963 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 3 0.0001
964 DEATH 55 0.0001
965 PROSTATE CANCER 5 0.0001
966 FEBRILE NEUTROPENIA 4 0.0001
967 AGGRESSION 3 0.0001
968 GASTRIC DISORDER 2 0.0001
969 DEVICE USE ERROR 2 0.0001
970 INJURY 4 0.0001
971 PANCREATITIS 3 0.0001
972 BRADYCARDIA 3 0.0001
973 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
974 NO ADVERSE EVENT 10 0.0001
975 C-REACTIVE PROTEIN INCREASED 2 0.0001
976 ACCIDENTAL OVERDOSE 2 0.0001
977 SUICIDAL IDEATION 5 0.0001
978 NEUTROPENIA 7 0.0001
979 DISEASE PROGRESSION 6 0.0001
980 ABORTION SPONTANEOUS 2 0.0000
981 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
982 TREATMENT FAILURE 4 0.0000
983 EXPOSURE DURING PREGNANCY 3 0.0000
984 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
985 DEVICE LEAKAGE 2 0.0000
986 PRODUCT STORAGE ERROR 4 0.0000
987 DRUG EFFECT DECREASED 2 0.0000
988 PRODUCT QUALITY ISSUE 5 0.0000
989 DEVICE ISSUE 3 0.0000
990 BREAST CANCER 3 0.0000
991 MALIGNANT NEOPLASM PROGRESSION 3 0.0000